Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


George, We Need a Budget for Growth

20 March 2012

By Stephen Caddick  Vice-Provost (Enterprise) at UCL
Abolishing the 50p tax rate, a mansion tax, slashing fuel duty - speculation has been rife in the last few weeks on the surprises which might be in this year's Budget.

Undoubtedly these are all important changes which will affect people quite significantly, if enacted. Yet behind the headlines and the gimmicks, this needs to be a Budget that gets the British economy moving again. So just like millions of others, I'll be watching closely on Wednesday to see if it will do just that.

Read the full article at www.huffingtonpost.co.uk